Skip to main content
. 2020 Oct 29;21(11):105–114. doi: 10.1002/acm2.13040

Table 5.

TRs, EUDs and MUs for left and right breast GRID plans.

Case # TR (C1/N1) TR (C2/N1)

EUD (Gy)

C1 (MLQ)

EUD (Gy)

C2 (MLQ)

EUD (Gy)

C1 (Niemierko)

EUD (Gy)

C2 (Niemierko)

MUs
Left breast
L1 9.61 7.53 8.83 8.67 9.45 9.78 2557
L2 10.54 8.33 8.69 8.54 9.34 9.69 2603
L3 9.53 7.48 8.92 8.77 9.46 9.71 2403
L4 13.92 10.94 8.83 8.68 9.46 9.85 2681
L5 11.03 8.76 8.69 8.54 9.27 9.58 2601
L6 12.08 9.72 8.39 8.25 9.00 9.33 2567
Average 11.12 8.79 8.73 8.58 9.33 9.66 2569
Right breast
R1 9.76 7.66 8.90 8.75 9.48 9.78 2636
R2 12.08 9.28 9.04 8.87 9.69 10.03 2680
R3 9.62 7.52 8.88 8.73 9.51 9.83 2730
R4 9.80 7.69 8.77 8.61 9.37 9.68 2586
R5 11.27 8.84 8.79 8.63 9.44 9.79 2605
R6 10.66 8.30 8.80 8.64 9.44 9.77 2526
Average 10.53 8.22 8.86 8.71 9.49 9.81 2627

TR (C1/N1): if the radiosensitive normal tissue N1 was interspersed in the breast cancer C1. TR (C2/N1): if the radiosensitive normal tissue N1 was interspersed in the breast cancer C2.